Submit Content
Get the latest delivered to your inbox
Privacy Policy

Biogen

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media - Twitter, LinkedIn, Facebook, YouTube.

    Biogen Recognized As One of America's Most JUST Companies Image

    POSTED 

    01-13-22

    Biogen Recognized As One of America's Most JUST Companies

    Biogen was recognized as #36 of 954 companies, reflecting our performance and sustained commitment to ESG.
    Biogen Leads From the Top With Disability Inclusion Image

    POSTED 

    12-03-21

    Biogen Leads From the Top With Disability Inclusion

    Biogen CEO Michel Vounatsos recently signed the Disability:IN’s CEO Letter on Disability Inclusion. We are proud we scored 100% on the Disability Equality Index for four consecutive years.
    From Pause to Pride: A Mother's Journey Image

    POSTED 

    12-01-21

    From Pause to Pride: A Mother's Journey

    Valencia Foster is a Senior Manager in Marketing and a Biogen employee of 18 years. Her son Miles came to her when he was 15 and told her he is bisexual. Valencia reflects on her journey toward acceptance and ultimately to LGBTQ ally and advocate.
    Youth Neurology Program: Building a More Diverse Neurology Workforce Image

    POSTED 

    11-30-21

    Youth Neurology Program: Building a More Diverse Neurology Workforce

    Neurological conditions such as stroke, Alzheimer’s disease and Parkinson’s disease are leading causes of disability and premature death, afflicting women, people of color and low-income communities at much higher rates than average.
    Wanda Castro-Borrero: Carrying on Legacy of Care Image

    POSTED 

    11-23-21

    Wanda Castro-Borrero: Carrying on Legacy of Care

    Growing up in Puerto Rico, Wanda Castro-Borrero came from a family of modest means and saw what unmet medical need looks like. Her childhood experiences sparked a passion to help others.
    Biogen Sets Industry Record with Recognition on Dow Jones Sustainability World Index for 9th Consecutive Year Image

    POSTED 

    11-15-21

    Biogen Sets Industry Record with Recognition on Dow Jones Sustainability World Index for 9th Consecutive Year

    Biogen’s recognition is a testament to its ongoing efforts to address the urgent & long-term challenges facing humanity, including health equity; the climate crisis; and human capital development with a focus on diversity, equity and inclusion.
    Introducing Biogen's 2021 Diversity, Equity & Inclusion Report Image

    POSTED 

    11-04-21

    Introducing Biogen's 2021 Diversity, Equity & Inclusion Report

    Diversity makes us stronger and helps drive innovation.
    A Letter From Alphonse Galdes, Ph.D., Head of Pharmaceutical Operations and Technology at Biogen: It's Time for Companies to Act Like the Climate Crisis Is a Health Crisis Image

    POSTED 

    11-03-21

    A Letter From Alphonse Galdes, Ph.D., Head of Pharmaceutical Operations and Technology at Biogen: It's Time for Companies to Act Like the Climate Crisis Is a Health Crisis

    If we hope to make significant, lasting progress against climate change, we as a society must all work together. Here are three key priorities that, if embraced, could galvanize action
    Healthy Climate, Healthy Lives: Fossil Fuel Free Operations Image

    POSTED 

    09-30-21

    Healthy Climate, Healthy Lives: Fossil Fuel Free Operations

    In September 2020, Biogen launched a a 20-year, $250m commitment to eliminate fossil fuel emissions from its operations by 2040 and advance action on the deeply interconnected challenges of climate, health and equity.
    Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative Image

    POSTED 

    09-23-21

    Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative

    The report details Biogen's efforts to go fossil fuel free, engagement with employees and suppliers, and collaborations with renowned institutions to improve health – especially for vulnerable populations most impacted by climate-related events.
    Biogen Logo

    Biogen

    Biogen

    Join today and get the latest delivered to your inbox